Company / EPS (Basic)
Twist Bioscience Corp EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.30
FY2025
5-year range
-$4.04 / -$1.30
FY2021-FY2025
Trend
+63.9%
vs FY2024
Sector context
#97 of 208
Health Care
What the data says
At $-1.30, Twist Bioscience Corp's eps (basic) ranks #97 of 208 in the Health Care sector. Improved from $-3.60 to $-1.30 over the past 2 years.
Based on SEC 10-K filings.
-1.30 in FY2025.
Improved from $-3.60 to $-1.30 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 208 in Health CareTop 47% of 208This company -$1.30 Sector average -$1.02
▼
-27.9% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 63.9% year-over-year.
- Ranks #97 out of 208 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.30 | +63.9% |
| FY2024 | -$3.60 | +0.0% |
| FY2023 | -$3.60 | +10.9% |
| FY2022 | -$4.04 | -28.3% |
| FY2021 | -$3.15 | +11.8% |
| FY2020 | -$3.57 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026